Syntrophobacterales
Syntrophobacterales is an order of bacteria that belongs to the class Deltaproteobacteria. This order is characterized by its unique metabolic capabilities, which allow it to thrive in environments where other bacteria cannot survive.
Taxonomy[edit]
The order Syntrophobacterales is divided into two families: Syntrophobacteraceae and Syntrophaceae. These families are further divided into several genera, including Syntrophobacter, Syntrophus, and Smithella.
Metabolism[edit]
Syntrophobacterales are known for their ability to degrade fatty acids in the absence of oxygen. This process, known as anaerobic fatty acid degradation, is unique to this order of bacteria. The bacteria convert the fatty acids into hydrogen and carbon dioxide, which are then used by other bacteria in the environment. This symbiotic relationship is known as syntrophy, which is where the order gets its name.
Ecology[edit]
Syntrophobacterales are found in a variety of environments, including soil, sediment, and the digestive tracts of animals. They play a crucial role in the carbon cycle, helping to break down organic matter and release carbon dioxide into the atmosphere.
Health implications[edit]
While Syntrophobacterales are not typically pathogenic, they can be found in the human gut and have been linked to certain health conditions. For example, an overabundance of these bacteria has been associated with inflammatory bowel disease.
Research[edit]
Research into Syntrophobacterales is ongoing, with scientists hoping to better understand their unique metabolic processes and their role in the environment and human health.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian